A novel synthesis, analysis and evaluation of Musa coccinea based zero valent iron nanoparticles for antimicrobial and antioxidant

Zero-valent Iron Nanoparticles: Biogenic Synthesis and their Medical Applications; Existing Challenges and Future Prospects

OBJECTIVES

In the last decade, nanobiotechnology is emerging as a keen prudence area owing to its widespread applications in the medical field. In this context, zero-valent iron nanoparticles (nZVI) have garnered tremendous attention attributed to their cheap, non-toxic, excellent paramagnetic nature, extremely reactive surface, and dual oxidation state that makes them excellent antioxidants and free-radical scavengers. Facile biogenic synthesis, in which a biological source is used as a template for the synthesis of NPs, is presumably dominant among other physical and chemical synthetic procedures. The purpose of this review is to elucidate plant-mediated synthesis of nZVI, although they have been successfully fabricated by microbes and other biological entities (such as starch, chitosan, alginate, cashew nut shell, etc.) as well.

METHODS

The methodology of the study involved keyword searches of electronic databases, including ScienceDirect, NCBI, and Google Scholar (2008-2023). Search terms of the review included 'biogenic synthesis of nZVI', 'plant-mediated synthesis of nZVI', 'medical applications of nZVI', and 'Recent advancements and future prospects of nZVI'.

RESULTS

Various articles were identified and reviewed for biogenic fabrication of stable nZVI with the vast majority of studies reporting positive findings. The resultant nanomaterial found great interest for biomedical purposes such as their use as biocompatible anticancer, antimicrobial, antioxidant, and albumin binding agents that have not been adequately accessed in previous studies.

CONCLUSION

This review shows that there are potential cost savings applications to be made when using biogenic nZVI for medical purposes. However, the encountering challenges concluded later, along with the prospects for sustainable future development.

Therapeutic and antioxidant potential of bionanofactory Ochrobactrum sp.-mediated magnetite and zerovalent iron nanoparticles against acute experimental toxoplasmosis

The control of toxoplasmosis, a rampant one health disease, has been focussed on conventional antitoxoplasmic agents with their adverse outcomes, including serious side effects, treatment failure and emergence of drug resistant strains. Nanobiotechnology may provide a strong impetus for versatile alternative therapies against toxoplasmosis. Bionanofactory Ochrobactrum sp. strain CNE2 was recruited for the biosynthesis of functionalized magnetite iron nanoparticles (MNPs) and nanozerovalent iron (nZVI) under aerobic and anaerobic conditions and their therapeutic efficacy was evaluated against acute toxoplasmosis in murine model. The formation of self-functionalized spherical nanoparticles varied in size, identity and surface properties were substantiated. Mice were orally administered 20 mg/kg of each formulation on the initial day of infection and continued for seven consecutive days post infection (PI). Parasitological, ultrastructural, immunological, and biochemical studies were performed for assessment of therapeutic activity of biogenic iron nanoparticles (INPs). Parasitologically, MNPs showed the highest antitoxoplasmic efficacy in terms of 96.82% and 91.87% reduction in mean tachyzoite count in peritoneal fluid and liver impression smears, respectively. Lesser percentage reductions were recorded in nZVI-treated infected subgroup (75.44% and 69.04%). In addition, scanning electron microscopy (SEM) examination revealed remarkable reduction in size and extensive damage to the surface of MNPs-treated tachyzoites. MNPs-treated infected mice revealed a statistically significant increase in the serum levels of both interferon gamma (IFN-γ) to 346.2 ± 4.6 pg/ml and reduced glutathione (GSH) to 8.83 ± 0.30 mg/dl that subsequently exerted malondialdehyde (MDA) quenching action. MNPs showed a superior promising antitoxoplasmic activity with respect to both spiramycin (SPI) and nZVI. To best of our knowledge, this is the first study of a bio-safe oral iron nanotherapeutic agent fabricated via an eco-friendly approach that offers promising potential against acute experimental toxoplasmosis.

Spectrophotometrically, Spectroscopically, Microscopically and Thermogravimetrically Optimized TiO2 and ZnO Nanoparticles and their Bactericidal, Antioxidant and Cytotoxic Potential: A Novel Comparative Approach

Current study was aimed to determine the antibacterial, antioxidant and cytotoxic potential of Titanium dioxide nanoparticles (TiO2NPs) and Zinc oxide nanoparticles (ZnONPs). Nanoparticles were characterized by UV-Vis spectrophotometry, particle size analyzer (PSA), fourier transform infrared (FTIR) spectroscopy, scanning electron microscopy (SEM), and thermogravimetric analysis (TGA). The Minimum inhibitory concentration (MIC) was determined by standard agar dilution method. Antibacterial potential of nanoparticles was analyzed by standard disc diffusion method against bacterial strains including Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumonia. Different concentrations of NPs (0.2, 0.4, 0.6, 0.8, 1.0, 1.2 and 1.4 mg/mL) were incorporated to evaluate the antimicrobial activity. Antioxidant activity and cytotoxicity of these NPs was analyzed by DPPH method and brine shrimp cytotoxicity assay, respectively. The MIC of TiO2NPs against E. coli, P. aeruginosa and K. pneumoniae was 0.04, 0.08 and 0.07 mg/mL respectively while the MIC of ZnONPs against the above strains was 0.01, 0.015 and 0.01 mg/mL. The maximum zone of inhibition was observed for K. pneumoniae i.e., 20mm and 25mm against TiO2 and ZnO NPs respectively, at 1.4 mg/mL concentration of NPs. The susceptibility of NPs against bacterial strains was evaluated in the following order: K. pneumoniae > P. aeruginosa > E. coli. The antioxidant activity of nanoparticles increased by increasing the concentration of NPs while cytotoxic analysis exhibited non-toxic effect of ZnO NPs while TiO2 had toxic effects on 1.2 and 1.4 mg/mL concentrations. Results revealed that ZnO NPs have more antibacterial and negligible cytotoxic potential in contrast to TiO2 NPs.

Biosynthesis of bionanomaterials using Bacillus cereus for the recovery of rare earth elements from mine wastewater

The growing demand for rare earth elements (REEs) increasingly requires secondary resources such as mine wastewater containing high concentrations of REEs, to be used as a source of REEs. The current challenge is how to efficiently recover REEs from this feed source. In this paper, a functional bionanomaterial (FeNPs-EPS) was biosynthesized using Bacillus cereus as a possible means of recovering REEs. This composite was composed of both synthesized iron nanoparticles (FeNPs) and extracellular polymeric substances (EPS). Synthesis of the FeNPs-EPS composite via a one-step biosynthesis was confirmed by materials characterization. The peak in the material's UV-Vis spectra at 511 nm demonstrates the formation of FeNPs-EPS, where 3D-EEM showed that FeNPs-EPS was wrapped predominantly with tryptophan protein-like and humic acid-like substances. In addition, while FTIR indicated that the functional groups present in EPS where virtually identical to those observed in FeNPs-EPS, XPS demonstrated that Fe and O were the major elemental present as both FeO and Fe₂O₃. Zeta potential measurements indicated that FeNPs-EPS had good stability under different pH conditions, where BET analysis supported multilayer adsorption. Finally, on exposure to high concentrations of Eu(III) and Tb(III) in mine wastewater, the synthesized FeNPs-EPS demonstrated strong potential to remove two cations from the wastewater and hence a potentially practical way to efficiently recover REEs from such waste streams.

Synergistic effect of hydrogen and nanoscale zero-valent iron on ex-situ biogas upgrading and acetate recovery

Hydrogen (H₂) assisted ex-situ biogas upgrading and liquid chemicals production can augment the fossil fuel-dominated energy market, and alleviate CO₂-induced global warming. Recent investigations confirmed that nanoscale zero-valent iron (nZVI) enabled the enhancement of anaerobic digestion for biogas production. However, little is known about the effect of nZVI on the downstream ex-situ biogas upgrading. Herein, different levels (0 mg L^-1, 100 mg L^-1, 200 mg L^-1, 500 mg L^-1, 1000 mg L^-1, 2000 mg L^-1) of nZVI were added for H₂-assisted ex-situ biogas upgrading, to study whether nZVI could impact the biomethane purity and acetate yield for the first time. Results showed that all tested nZVI levels were favorable for biogas upgrading in the presence of H₂, the highest biomethane content (94.1 %, v/v), the CO₂ utilization ratio (95.9 %), and acetate yield (19.4 mmol L^-1) were achieved at 500 mg L^-1 nZVI, respectively. Further analysis indicated that increased biogas upgrading efficiency was related to an increase in extracellular polymeric substances, which ensures the microbial activity and stability of the ex-situ biogas upgrading. Microbial community characterization showed that the Petrimonas, Romboutsia, Acidaminococcus, and Clostridium predominated the microbiome during biogas upgrading at 500 mg L^-1 nZVI with H₂ supply. These results suggested that nZVI and H₂ contributed jointly to promoting the bioconversion of CO₂ in biogas to acetate. The findings could be helpful for paving a new way for efficient simultaneous ex-situ biogas upgrading and liquid chemicals recovery.

Antibacterial, antifungal, antidiabetic, and antioxidant activities potential of Coleus aromaticus synthesized titanium dioxide nanoparticles

The nanoparticles based drug delivery and treatment related research has been increased significantly in the recent years. Hence, the antibacterial, antifungal, and antioxidant activity potential of pre synthesized and characterized Titanium dioxide nanoparticles (TiO₂ NPs) were investigated in this study through respective standard protocols. Interestingly, the obtained results revealed that TiO₂ NPs have concentration dependent antibacterial activity against bacterial pathogens such as E. coli, P.mirabilis, V. cholerae, P. aeruginosa, S. typhimurium, and S. aureus at 100 μg mL^-1 concentration. Furthermore, these TiO₂ NPs showed remarkable antifungal activity against aspergillosis causing fungal pathogens such as A. niger, A. fumigatus, A. nidulans, and A. flavus at 100 μg mL^-1 concentration. α-glucosidase. This TiO₂ NPs also effectively inhibit the α-amylase (17%) and α-Glucosidase (37%) enzyme activity at 100 μg mL^-1 dosage. The DPPH assay revealed that TiO₂ NPs effectively scavenge DPPH free radicals by up to 89% at 100 μg mL^-1 concentration, which was comparable to butylated hydroxytoluene (96%). These results suggest that the plant-based TiO₂ NPs have remarkable in-vitro antibacterial, antifungal, and antioxidant activity. These may be considered for additional in-vitro and in-vivo experiments to assess their potential biomedical applications.